Candidiasis
📧 Sign up to get email alerts when something new happens for Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
Clinical trial update describing outcomes of patients with severe Candida albicans infections who did not respond to fluconazole treatment.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight [Phase 3]
A Phase 3 trial evaluated fluconazole prophylaxis to prevent candidiasis in extremely low birthweight infants (less than 750 grams).
-
FDA approval · 2014-01-07FDA Approved: DIFLUCAN — Supplemental Application (Roerig)
The FDA approved a Roerig supplemental application for DIFLUCAN (fluconazole).
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida [Phase 3]
A Phase 3 trial comparing anidulafungin to caspofungin for deep tissue infections due to Candida was terminated with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection [Phase 3]
Phase 3 pharmacokinetic study of the itraconazole oral solution JK1211 (Itrizole) in patients with invasive fungal infections; results have …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates [Phase 1]
This open-label Phase 1 study evaluated the safety and pharmacokinetics of repeated-dose micafungin in neonates with Candida infections.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom
A completed UK clinical trial update evaluating anidulafungin in patients with liver disease for candidiasis, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections [Phase 2]
A Phase 2 trial evaluating LAS41003 for candidiasis (including intertriginous Candida infections) has completed, with efficacy and safety as…
-
FDA approval · 2012-06-21FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for NOXAFIL (posaconazole) from Merck Sharp & Dohme LLC, indicating an update to the NDA under t…
-
FDA approval · 2012-05-30FDA Approved: VORICONAZOLE — Original Application (Sandoz Inc)
The FDA approved Sandoz Inc's original application for a generic Voriconazole, enabling its marketing in the United States for the same indi…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida [Phase 1]
Phase 1 safety and immunogenicity study of the recombinant NDV-3 vaccine targeting Staphylococcus aureus and Candida infections has been com…
-
FDA approval · 2012-01-30FDA Approved: FLUCONAZOLE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic fluconazole to treat fungal infections, including candidias…
-
FDA approval · 2012-01-25FDA Approved: FLUCONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for fluconazole submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2011-12-01Clinical Trial Update: Role of Polymorphisms in the Dectin-1 Gene in Determining the Risk of Candida Colonization and Infection in Critically Ill Patients
The document reports a clinical trial exploring whether polymorphisms in the Dectin-1 gene influence the risk of Candida colonization and in…
-
FDA approval · 2011-10-13FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluconazole by Rising Pharma Holdings, Inc., authorizing an updated generic product under the AN…
-
FDA approval · 2011-08-25FDA Approved: KETOCONAZOLE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Ketoconazole original application (ANDA 091550) for a generic ketoconazole product.
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants [Phase 4]
Phase 4 clinical trial comparing Saccharomyces boulardii with nystatin prophylaxis to prevent Candida colonization and infection in very low…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of voriconazole for fungal infections has completed. The study included candidia…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. [Phase 3]
A Phase 3 study comparing voriconazole to amphotericin B followed by fluconazole in patients with candidemia has completed.
-
CLINICAL_TRIALS research · 2011-03-16Clinical Trial Update: Pre-hospital Risk Factors for Invasive Fungal Infection
This clinical trial update discusses pre-hospital risk factors for invasive fungal infections in patients with acute myeloid leukemia and re…
-
FDA approval · 2011-03-07FDA Approved: FLUCONAZOLE — Original Application (ANI Pharmaceuticals, Inc.)
ANI Pharmaceuticals received FDA approval for an original generic application of fluconazole.
-
FDA approval · 2011-02-04FDA Approved: KETOCONAZOLE — Supplemental Application (Northstar Rx LLC)
The FDA approved a supplemental application for Ketoconazole submitted by Northstar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection [Phase 2]
This Phase 2 study reports on the pharmacokinetics and safety of voriconazole in children aged 2 to 11 at high risk for systemic fungal infe…
-
FDA approval · 2010-11-21FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig. The supplement updates the labeling for the antifungal…
-
FDA approval · 2010-09-17FDA Approved: NIZORAL — Supplemental Application (Kramer Laboratories)
FDA approved a supplemental application for NIZORAL (ketoconazole) from Kramer Laboratories, resulting in labeling updates for the product.